TSH Receptor Mutations Among a Consanguineous Community
Public ClinicalTrials.gov record NCT00747760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Prevalence of TSH Receptor Mutation Among the Arab Population of Israel
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Resistance to thyrotropin (RTSH) is a condition of impaired responsiveness of the thyroid gland to TSH, characterized by elevated TSH, low or normal thyroid hormone levels, and hypoplastic or normal-sized thyroid gland. The aim of the present study was to evaluate the clinical course over time,the genotype-phenotype association and the frequency of two different TSH-receptor (TSHR) mutations in a highly consanguineous population of the town of Um-El-Fahem.
Study identification
- NCT ID
- NCT00747760
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 209 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Jun 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Sep 10, 2008
2005 – 2006
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Samuell Refetoff | Chicago | Illinois | 60637-1470 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
Recently updated Hypothyroidism trials
Other public records listing Hypothyroidism. Sorted by last update posted; newest first. Not a recommendation.
- NCT07787585: Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism Not yet recruiting
- NCT07747103: An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets. Recruiting
- NCT00001159: Natural History of Thyroid Function Disorders Recruiting
- NCT07060118: Gluten Free Diet in Hashimoto's Hypothyroidism Active, not recruiting
- NCT06731764: Novel Approaches to the Treatment of Hypothyroidism Recruiting
- NCT06073665: Dosing of LT4 in Older Individuals Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00747760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2008 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00747760 live on ClinicalTrials.gov.